escitalopram has been researched along with Affective Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, K; Chandrasena, G; Desai, M; Jubian, V; Lu, Y; Marzabadi, MR; Noble, SA; Packiarajan, M; Walker, MW; Wiborg, O; Wolinsky, TD; Wong, WC; Zhong, H | 1 |
| Bosi, MF; Cafaro, R; Cetin, I; Clementi, E; Colombo, A; Dell'Osso, B; Di Bernardo, I; Giordano, F; Giorgetti, F; Pileri, P; Varinelli, A; Viganò, CA | 1 |
2 other study(ies) available for escitalopram and Affective Disorders
| Article | Year |
|---|---|
Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder.
Topics: Animals; Benzothiepins; Biological Availability; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Mice; Molecular Structure; Mood Disorders; Rats; Receptors, Neuropeptide Y; Stereoisomerism; Structure-Activity Relationship; Sulfonamides | 2011 |
Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affec
Topics: Citalopram; Escitalopram; Female; Humans; Mood Disorders; Pharmacogenetics; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |